abstract |
Novel pyridine compounds and the pharmaceutically acceptable salts thereof having a specific inhibitory activity on thromboxane A 2 biosynthesis in mammals useful for prevention and treatment of various disorders caused by thromboxane A 2 , for example, thrombosis, cardiac infarction, diabetic vascular complications, asthma, etc. are disclosed. |